Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,061 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.
Espinel-Ingroff A, Bartlett M, Bowden R, Chin NX, Cooper C Jr, Fothergill A, McGinnis MR, Menezes P, Messer SA, Nelson PW, Odds FC, Pasarell L, Peter J, Pfaller MA, Rex JH, Rinaldi MG, Shankland GS, Walsh TJ, Weitzman I. Espinel-Ingroff A, et al. Among authors: bartlett m. J Clin Microbiol. 1997 Jan;35(1):139-43. doi: 10.1128/jcm.35.1.139-143.1997. J Clin Microbiol. 1997. PMID: 8968895 Free PMC article.
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.
Espinel-Ingroff A, Bartlett M, Chaturvedi V, Ghannoum M, Hazen KC, Pfaller MA, Rinaldi M, Walsh TJ. Espinel-Ingroff A, et al. Among authors: bartlett m. Antimicrob Agents Chemother. 2001 Jun;45(6):1828-35. doi: 10.1128/AAC.45.6.1828-1835.2001. Antimicrob Agents Chemother. 2001. PMID: 11353633 Free PMC article. Clinical Trial.
Collaborative investigation of variables in susceptibility testing of yeasts.
Pfaller MA, Rinaldi MG, Galgiani JN, Bartlett MS, Body BA, Espinel-Ingroff A, Fromtling RA, Hall GS, Hughes CE, Odds FC, et al. Pfaller MA, et al. Among authors: bartlett ms. Antimicrob Agents Chemother. 1990 Sep;34(9):1648-54. doi: 10.1128/AAC.34.9.1648. Antimicrob Agents Chemother. 1990. PMID: 2285276 Free PMC article. Clinical Trial.
Multicenter evaluation of four methods of yeast inoculum preparation.
Pfaller MA, Burmeister L, Bartlett MS, Rinaldi MG. Pfaller MA, et al. Among authors: bartlett ms. J Clin Microbiol. 1988 Aug;26(8):1437-41. doi: 10.1128/jcm.26.8.1437-1441.1988. J Clin Microbiol. 1988. PMID: 3049651 Free PMC article. Clinical Trial.
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts.
Fromtling RA, Galgiani JN, Pfaller MA, Espinel-Ingroff A, Bartizal KF, Bartlett MS, Body BA, Frey C, Hall G, Roberts GD, et al. Fromtling RA, et al. Among authors: bartlett ms. Antimicrob Agents Chemother. 1993 Jan;37(1):39-45. doi: 10.1128/AAC.37.1.39. Antimicrob Agents Chemother. 1993. PMID: 8431016 Free PMC article.
In combination with data from previous multicenter studies (National Committee for Clinical Laboratory Standards, Antifungal Susceptibility Testing: Committee Report, Vol. 5, No. 17, 1988; M. A. Pfaller, L. Burmeister, M. S. Bartlett, and M. G. Rinaldi …
In combination with data from previous multicenter studies (National Committee for Clinical Laboratory Standards, Antifungal Susceptibility …
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL. Rex JH, et al. Among authors: bartlett ms. Clin Infect Dis. 1997 Feb;24(2):235-47. doi: 10.1093/clinids/24.2.235. Clin Infect Dis. 1997. PMID: 9114154 Review.
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.
Odds FC, Van Gerven F, Espinel-Ingroff A, Bartlett MS, Ghannoum MA, Lancaster MV, Pfaller MA, Rex JH, Rinaldi MG, Walsh TJ. Odds FC, et al. Among authors: bartlett ms. Antimicrob Agents Chemother. 1998 Feb;42(2):282-8. doi: 10.1128/AAC.42.2.282. Antimicrob Agents Chemother. 1998. PMID: 9527773 Free PMC article.
1,061 results